PULMONX CORPORATION (LUNG) Shareholders’ equity 2018–2025
PULMONX CORPORATION (LUNG) shareholders’ equity at each fiscal year-end, per SEC filings.
$54.1MFY2025 · since FY2018: -$167.3M → $54.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.1M | -36.9% |
| FY2024 | $85.8M | -27.5% |
| FY2023 | $118.3M | -23.2% |
| FY2022 | $154.0M | -20.3% |
| FY2021 | $193.2M | -14.5% |
| FY2020 | $226.1M | +220.7% |
| FY2019 | -$187.4M | -12.0% |
| FY2018 | -$167.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice